AGM/EGMJul 23, 2026, 02:41 PM
Dr. Reddy's Laboratories 42nd AGM Resolutions Passed
AI Summary
Dr. Reddy's Laboratories Ltd. announced the outcome of its 42nd Annual General Meeting (AGM) held on July 23, 2026. All resolutions presented to the members were passed by the requisite majority. Key approvals included the adoption of financial statements for FY2025-26, the declaration of a final dividend of Rs. 8 per equity share, and the appointment/re-appointment of directors and auditors.
Key Highlights
- 42nd Annual General Meeting (AGM) held on July 23, 2026.
- All proposed resolutions at the AGM were passed by the requisite majority.
- Approved a final dividend of Rs. 8 per equity share for the financial year ended March 31, 2026.
- Adopted the audited financial statements for FY2025-26.
- Re-appointed Mr. K Satish Reddy as a Director.
- Appointed Deloitte Haskins & Sells, LLP as Statutory Auditors for five years.
- Re-appointed Dr. K P Krishnan and appointed Mr. Srikanth Velamakanni as Independent Directors.
- Ratified remuneration for cost auditors for the financial year ending March 31, 2027.
Price Impact
More from RDY